Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that the Company will present at the following upcoming investor conferences in June.
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in June:
- Jefferies Healthcare Conference (New York, NY): fireside chat on Wednesday, June 8, 2022 at 11:30am ET.
- Goldman Sachs Annual Global Healthcare Conference (Palos Verdes, CA): fireside chat on Monday, June 13, 2022 at 3:20pm PT (6:20pm ET).
A live webcast of each presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601006140/en/
Contacts
Investors
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com
Media
Becky Kern
914-772-2310
becky.kern@sagerx.com
Source: Sage Therapeutics, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20220601006140/en
